Pictet Asset Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.9M | Buy |
130,537
+65,275
| +100% | +$8.97M | 0.02% | 534 |
|
|
2025
Q1 | $11.8M | Sell |
65,262
-46,827
| -42% | -$8.44M | 0.01% | 617 |
|
|
2024
Q4 | $17.6M | Sell |
112,089
-3,261
| -3% | -$511K | 0.02% | 542 |
|
|
2024
Q3 | $21M | Sell |
115,350
-22,083
| -16% | -$4.02M | 0.02% | 487 |
|
|
2024
Q2 | $25.2M | Sell |
137,433
-5,527
| -4% | -$1.01M | 0.03% | 408 |
|
|
2024
Q1 | $25.4M | Sell |
142,960
-49,915
| -26% | -$8.88M | 0.03% | 436 |
|
|
2023
Q4 | $23.9M | Sell |
192,875
-180,937
| -48% | -$22.4M | 0.03% | 437 |
|
|
2023
Q3 | $43.4M | Buy |
+373,812
| New | +$43.4M | 0.05% | 309 |
|